nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0788	0.126	CbGbCtD
Rifaximin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0741	0.119	CbGbCtD
Rifaximin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0741	0.119	CbGbCtD
Rifaximin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.067	0.107	CbGbCtD
Rifaximin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.067	0.107	CbGbCtD
Rifaximin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0579	0.0925	CbGbCtD
Rifaximin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0562	0.0898	CbGbCtD
Rifaximin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0508	0.0812	CbGbCtD
Rifaximin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0508	0.0812	CbGbCtD
Rifaximin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0487	0.0779	CbGbCtD
Rifaximin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.000836	CcSEcCtD
Rifaximin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000313	0.000836	CcSEcCtD
Rifaximin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000313	0.000836	CcSEcCtD
Rifaximin—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.000832	CcSEcCtD
Rifaximin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000311	0.000831	CcSEcCtD
Rifaximin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000311	0.00083	CcSEcCtD
Rifaximin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00031	0.000829	CcSEcCtD
Rifaximin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.000828	CcSEcCtD
Rifaximin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.000828	CcSEcCtD
Rifaximin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00031	0.000827	CcSEcCtD
Rifaximin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.000825	CcSEcCtD
Rifaximin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.000825	CcSEcCtD
Rifaximin—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.000823	CcSEcCtD
Rifaximin—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000307	0.000821	CcSEcCtD
Rifaximin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000307	0.000819	CcSEcCtD
Rifaximin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.000818	CcSEcCtD
Rifaximin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000306	0.000818	CcSEcCtD
Rifaximin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000306	0.000816	CcSEcCtD
Rifaximin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000305	0.000815	CcSEcCtD
Rifaximin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000305	0.000814	CcSEcCtD
Rifaximin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000305	0.000814	CcSEcCtD
Rifaximin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.000813	CcSEcCtD
Rifaximin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.000812	CcSEcCtD
Rifaximin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.000812	CcSEcCtD
Rifaximin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.000812	CcSEcCtD
Rifaximin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000303	0.00081	CcSEcCtD
Rifaximin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000303	0.00081	CcSEcCtD
Rifaximin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.000807	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000302	0.000807	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000301	0.000804	CcSEcCtD
Rifaximin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000301	0.000803	CcSEcCtD
Rifaximin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000301	0.000803	CcSEcCtD
Rifaximin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.000803	CcSEcCtD
Rifaximin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.000802	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.000802	CcSEcCtD
Rifaximin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.000801	CcSEcCtD
Rifaximin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.0003	0.0008	CcSEcCtD
Rifaximin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000298	0.000796	CcSEcCtD
Rifaximin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000298	0.000796	CcSEcCtD
Rifaximin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000298	0.000796	CcSEcCtD
Rifaximin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.000796	CcSEcCtD
Rifaximin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000297	0.000794	CcSEcCtD
Rifaximin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.000792	CcSEcCtD
Rifaximin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.000792	CcSEcCtD
Rifaximin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000296	0.000791	CcSEcCtD
Rifaximin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.00079	CcSEcCtD
Rifaximin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000295	0.000788	CcSEcCtD
Rifaximin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000295	0.000788	CcSEcCtD
Rifaximin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.000787	CcSEcCtD
Rifaximin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000295	0.000787	CcSEcCtD
Rifaximin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.000785	CcSEcCtD
Rifaximin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.000785	CcSEcCtD
Rifaximin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000294	0.000784	CcSEcCtD
Rifaximin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.000782	CcSEcCtD
Rifaximin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.000782	CcSEcCtD
Rifaximin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.000782	CcSEcCtD
Rifaximin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000291	0.000777	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000291	0.000776	CcSEcCtD
Rifaximin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.000772	CcSEcCtD
Rifaximin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.00077	CcSEcCtD
Rifaximin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000287	0.000767	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.000767	CcSEcCtD
Rifaximin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.000766	CcSEcCtD
Rifaximin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.000765	CcSEcCtD
Rifaximin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000286	0.000764	CcSEcCtD
Rifaximin—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.000764	CcSEcCtD
Rifaximin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000286	0.000764	CcSEcCtD
Rifaximin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.000763	CcSEcCtD
Rifaximin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000285	0.000762	CcSEcCtD
Rifaximin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000285	0.000762	CcSEcCtD
Rifaximin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000285	0.000761	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000284	0.00076	CcSEcCtD
Rifaximin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000284	0.000759	CcSEcCtD
Rifaximin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000284	0.000759	CcSEcCtD
Rifaximin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.000756	CcSEcCtD
Rifaximin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.000756	CcSEcCtD
Rifaximin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.000753	CcSEcCtD
Rifaximin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.000752	CcSEcCtD
Rifaximin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.000752	CcSEcCtD
Rifaximin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000282	0.000752	CcSEcCtD
Rifaximin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000281	0.000752	CcSEcCtD
Rifaximin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000281	0.000751	CcSEcCtD
Rifaximin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000281	0.000751	CcSEcCtD
Rifaximin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00028	0.000748	CcSEcCtD
Rifaximin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.000746	CcSEcCtD
Rifaximin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.000746	CcSEcCtD
Rifaximin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.000746	CcSEcCtD
Rifaximin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.000744	CcSEcCtD
Rifaximin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.000742	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000277	0.000741	CcSEcCtD
Rifaximin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00074	CcSEcCtD
Rifaximin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.000737	CcSEcCtD
Rifaximin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.000737	CcSEcCtD
Rifaximin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000276	0.000736	CcSEcCtD
Rifaximin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000276	0.000736	CcSEcCtD
Rifaximin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.000735	CcSEcCtD
Rifaximin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000275	0.000735	CcSEcCtD
Rifaximin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000274	0.000733	CcSEcCtD
Rifaximin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.000732	CcSEcCtD
Rifaximin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.000729	CcSEcCtD
Rifaximin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000273	0.000729	CcSEcCtD
Rifaximin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000273	0.000728	CcSEcCtD
Rifaximin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.000728	CcSEcCtD
Rifaximin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.000727	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.000727	CcSEcCtD
Rifaximin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000272	0.000726	CcSEcCtD
Rifaximin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.000726	CcSEcCtD
Rifaximin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000272	0.000726	CcSEcCtD
Rifaximin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.000725	CcSEcCtD
Rifaximin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.000724	CcSEcCtD
Rifaximin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000271	0.000724	CcSEcCtD
Rifaximin—Headache—Stavudine—acquired immunodeficiency syndrome	0.00027	0.000722	CcSEcCtD
Rifaximin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00027	0.000722	CcSEcCtD
Rifaximin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.000721	CcSEcCtD
Rifaximin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00072	CcSEcCtD
Rifaximin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00072	CcSEcCtD
Rifaximin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.00072	CcSEcCtD
Rifaximin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000269	0.000718	CcSEcCtD
Rifaximin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000268	0.000716	CcSEcCtD
Rifaximin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000268	0.000715	CcSEcCtD
Rifaximin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.000715	CcSEcCtD
Rifaximin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.000714	CcSEcCtD
Rifaximin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000266	0.000711	CcSEcCtD
Rifaximin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00071	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.000709	CcSEcCtD
Rifaximin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000265	0.000709	CcSEcCtD
Rifaximin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.000708	CcSEcCtD
Rifaximin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.000704	CcSEcCtD
Rifaximin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.000703	CcSEcCtD
Rifaximin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.000701	CcSEcCtD
Rifaximin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.0007	CcSEcCtD
Rifaximin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.000699	CcSEcCtD
Rifaximin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.000696	CcSEcCtD
Rifaximin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.000696	CcSEcCtD
Rifaximin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.000694	CcSEcCtD
Rifaximin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.000694	CcSEcCtD
Rifaximin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.000694	CcSEcCtD
Rifaximin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.000691	CcSEcCtD
Rifaximin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000258	0.000688	CcSEcCtD
Rifaximin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000257	0.000686	CcSEcCtD
Rifaximin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000257	0.000686	CcSEcCtD
Rifaximin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000257	0.000685	CcSEcCtD
Rifaximin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000256	0.000684	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.000683	CcSEcCtD
Rifaximin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000681	CcSEcCtD
Rifaximin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.000678	CcSEcCtD
Rifaximin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.000677	CcSEcCtD
Rifaximin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000252	0.000674	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.000672	CcSEcCtD
Rifaximin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.000671	CcSEcCtD
Rifaximin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.000669	CcSEcCtD
Rifaximin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00025	0.000668	CcSEcCtD
Rifaximin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.000668	CcSEcCtD
Rifaximin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.000668	CcSEcCtD
Rifaximin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.000666	CcSEcCtD
Rifaximin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.000666	CcSEcCtD
Rifaximin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000666	CcSEcCtD
Rifaximin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000666	CcSEcCtD
Rifaximin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000248	0.000662	CcSEcCtD
Rifaximin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000247	0.000659	CcSEcCtD
Rifaximin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.000651	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.000651	CcSEcCtD
Rifaximin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.000648	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.000647	CcSEcCtD
Rifaximin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000647	CcSEcCtD
Rifaximin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.000646	CcSEcCtD
Rifaximin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.000642	CcSEcCtD
Rifaximin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000641	CcSEcCtD
Rifaximin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000641	CcSEcCtD
Rifaximin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000637	CcSEcCtD
Rifaximin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000239	0.000637	CcSEcCtD
Rifaximin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.000637	CcSEcCtD
Rifaximin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.000637	CcSEcCtD
Rifaximin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.000631	CcSEcCtD
Rifaximin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.000631	CcSEcCtD
Rifaximin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.000631	CcSEcCtD
Rifaximin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000235	0.000627	CcSEcCtD
Rifaximin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.000623	CcSEcCtD
Rifaximin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000621	CcSEcCtD
Rifaximin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00062	CcSEcCtD
Rifaximin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000618	CcSEcCtD
Rifaximin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.000617	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.000617	CcSEcCtD
Rifaximin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.000616	CcSEcCtD
Rifaximin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000231	0.000616	CcSEcCtD
Rifaximin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000615	CcSEcCtD
Rifaximin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000615	CcSEcCtD
Rifaximin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000613	CcSEcCtD
Rifaximin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000611	CcSEcCtD
Rifaximin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000611	CcSEcCtD
Rifaximin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000604	CcSEcCtD
Rifaximin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.000602	CcSEcCtD
Rifaximin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000596	CcSEcCtD
Rifaximin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000595	CcSEcCtD
Rifaximin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000223	0.000595	CcSEcCtD
Rifaximin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000592	CcSEcCtD
Rifaximin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000592	CcSEcCtD
Rifaximin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000222	0.000592	CcSEcCtD
Rifaximin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000589	CcSEcCtD
Rifaximin—Rash—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000587	CcSEcCtD
Rifaximin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000587	CcSEcCtD
Rifaximin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000585	CcSEcCtD
Rifaximin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000218	0.000583	CcSEcCtD
Rifaximin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.000582	CcSEcCtD
Rifaximin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.000576	CcSEcCtD
Rifaximin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000574	CcSEcCtD
Rifaximin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000568	CcSEcCtD
Rifaximin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000565	CcSEcCtD
Rifaximin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000565	CcSEcCtD
Rifaximin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.000559	CcSEcCtD
Rifaximin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000559	CcSEcCtD
Rifaximin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000557	CcSEcCtD
Rifaximin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000555	CcSEcCtD
Rifaximin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000554	CcSEcCtD
Rifaximin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000207	0.000553	CcSEcCtD
Rifaximin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000552	CcSEcCtD
Rifaximin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000551	CcSEcCtD
Rifaximin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000551	CcSEcCtD
Rifaximin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000538	CcSEcCtD
Rifaximin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000535	CcSEcCtD
Rifaximin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000533	CcSEcCtD
Rifaximin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000531	CcSEcCtD
Rifaximin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.00053	CcSEcCtD
Rifaximin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.00053	CcSEcCtD
Rifaximin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000527	CcSEcCtD
Rifaximin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000527	CcSEcCtD
Rifaximin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000523	CcSEcCtD
Rifaximin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000515	CcSEcCtD
Rifaximin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000513	CcSEcCtD
Rifaximin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000513	CcSEcCtD
Rifaximin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000506	CcSEcCtD
Rifaximin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.0005	CcSEcCtD
Rifaximin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000496	CcSEcCtD
Rifaximin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000495	CcSEcCtD
Rifaximin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000491	CcSEcCtD
Rifaximin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00049	CcSEcCtD
Rifaximin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000489	CcSEcCtD
Rifaximin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000488	CcSEcCtD
Rifaximin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000476	CcSEcCtD
Rifaximin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000473	CcSEcCtD
Rifaximin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000472	CcSEcCtD
Rifaximin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000472	CcSEcCtD
Rifaximin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000469	CcSEcCtD
Rifaximin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000462	CcSEcCtD
Rifaximin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000455	CcSEcCtD
Rifaximin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000451	CcSEcCtD
Rifaximin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.00045	CcSEcCtD
Rifaximin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000448	CcSEcCtD
Rifaximin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000445	CcSEcCtD
Rifaximin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000425	CcSEcCtD
